02 October 2026 – The South African Health Products Regulatory Authority (SAHPRA) wishes to alert all stakeholders to phishing emails currently circulating with the subject lines “Urgent” and “Follow-Up”. SAHPRA is aware that some stakeholders have already clicked on links contained in these emails. Stakeholders who have...
18 September 2026 – The South African Health Products Regulatory Authority (SAHPRA) is participating in the 70th International Atomic Energy Agency (IAEA) General Conference in Vienna, underscoring its critical role in ensuring the safe and responsible use of radiation in healthcare. At the conference, SAHPRA contributed...
14 September 2026 – The South African Health Products Regulatory Authority (SAHPRA) hosted a three-day bilateral engagement with Lesotho’s Radiation Protection Agency (RPA) at its Pretoria head office. The meeting promoted knowledge sharing in radiation regulation and regulatory excellence, with the RPA delegation comprising executive...
26 August 2026 – The South African Health Products Regulatory Authority (SAHPRA) is pleased to share that the World Health Organization (WHO) has confirmed that South Africa has achieved and maintained Maturity Level 3 (ML3) for the regulation of vaccines (producing), as of 18 August...
20 August 2026 – The South African Health Products Regulatory Authority (SAHPRA) wishes to reaffirm the public that routine childhood vaccines used in South Africa remain safe based on ongoing evidence and monitoring. SAHPRA continuously monitors the safety and quality of vaccines used in South Africa....
Pretoria, 17 August 2026 – Tshwane University of Technology (TUT) Faculty of Science students at the Arcadia Campus filled the Science Hall to welcome the South African Health Products Regulatory Authority (SAHPRA) as part of its ongoing programme to engage university students and raise...
Pretoria, 16 August 2026 – The South African Health Products Regulatory Authority (SAHPRA) has initiated the recall of four batches of Enalapril 10mg Arya, a medicine commonly used to treat high blood pressure (hypertension), following the identification of out-of-specification results during post-marketing surveillance inspections. The recall...
Pretoria, 20 July 2026 – Approximately 200 pharmacy and science students at Rhodes University gathered at the University's Makhanda campus, formerly Grahamstown, on 9 July to explore careers in health product regulation during the South African Health Products Regulatory Authority's (SAHPRA) participation in the University's...
Pretoria, 08 July 2026 – The South African Pharmacy Council (SAPC), Health Professions Council of South Africa (HPCSA) and the South African Health Products Regulatory Authority (SAHPRA) hereby warn the public, pharmacies and dispensing medical practitioners against any continued use, prescription and/or dispensing of iDEXIS...
Pretoria, 25 June 2026 - Since its establishment in 2018, the South African Health Products Regulatory Authority has maintained a strong focus on patient safety as a central pillar of its mandate. In terms of the Medicines and Related Substances Act, 1965 (Act 101 of...
